1102 related articles for article (PubMed ID: 11063139)
21. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
[TBL] [Abstract][Full Text] [Related]
22. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia.
Cacoub P; Renou C; Kerr G; Hüe S; Rosenthal E; Cohen P; Kaplanski G; Charlotte F; Thibault V; Ghillani P; Piette JC; Caillat-Zucman S
Arthritis Rheum; 2001 Sep; 44(9):2118-24. PubMed ID: 11592376
[TBL] [Abstract][Full Text] [Related]
23. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
Ahmad N; Asgher M; Shafique M; Qureshi JA
Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
[TBL] [Abstract][Full Text] [Related]
24. Anti-HCV and HCV-RNA prevalence and clinical correlations in cases with non-Hodgkin's lymphoma.
Paydas S; Kilic B; Yavuz S; Disel U; Tanriverdi K; Sahin B; Burgut R
Am J Hematol; 2003 Oct; 74(2):89-93. PubMed ID: 14508793
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
26. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
[TBL] [Abstract][Full Text] [Related]
27. Virological and histological features of hepatitis C virus (HCV) infection in kidney transplant recipients.
Fabrizi F; Lunghi G; Marai P; Marcelli D; Guarnori I; Raffaele L; Erba G; Pagano A; Locatelli F
Nephrol Dial Transplant; 1996 Jan; 11(1):159-64. PubMed ID: 8649626
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of hepatitis C virus associated cryoglobulinemia at a veterans hospital.
Kerr GS; Rofail M; Lewis JH; Kumar P; Seeff LB
J Rheumatol; 1997 Nov; 24(11):2134-8. PubMed ID: 9375872
[TBL] [Abstract][Full Text] [Related]
29. Cerebral ischemic attack secondary to hepatitis C virus infection.
Cojocaru IM; Cojocaru M; Iacob SA; Burcin C
Rom J Intern Med; 2005; 43(3-4):255-60. PubMed ID: 16812984
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus infection in Italian kidney graft recipients. Changing risk factors and hepatitis C virus genotypes.
Angelico M; Tisone G; Rapicetta M; Pisani F; Gandin C; Chionne P; Dettori S; Iaria G; Danese V; Orlando G; Casciani CU
Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):448-55. PubMed ID: 9494855
[TBL] [Abstract][Full Text] [Related]
31. Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: a prospective study.
Fabrizi F; Lunghi G; Guarnori I; Raffaele L; Crepaldi M; Pagano A; Locatelli F
Nephrol Dial Transplant; 1994; 9(11):1611-5. PubMed ID: 7532839
[TBL] [Abstract][Full Text] [Related]
32. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).
Couroucé AM; Bouchardeau F; Chauveau P; Le Marrec N; Girault A; Zins B; Naret C; Poignet JL
Nephrol Dial Transplant; 1995; 10(2):234-9. PubMed ID: 7538650
[TBL] [Abstract][Full Text] [Related]
34. Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study.
Dai CY; Chuang WL; Ho CK; Hsieh MY; Huang JF; Lee LP; Hou NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Tsai JF; Chang WY; Yu ML
J Hepatol; 2008 Jul; 49(1):9-16. PubMed ID: 18486265
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients.
Bonnet F; Pineau JJ; Taupin JL; Feyler A; Bonarek M; de Witte S; Bernard N; Lacoste D; Morlat P; Beylot J
J Rheumatol; 2003 Sep; 30(9):2005-10. PubMed ID: 12966606
[TBL] [Abstract][Full Text] [Related]
36. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
[TBL] [Abstract][Full Text] [Related]
37. [Extrahepatic manifestations of chronic hepatitis C].
Ignatova TM; Aprosina ZG; Serov VV; Mukhin NA; Krel' PE; Semenkova EN; Popova IV; Tanashchuk EL
Ter Arkh; 1998; 70(11):9-16. PubMed ID: 9949448
[TBL] [Abstract][Full Text] [Related]
38. [The presence of hepatitis C virus (HCV) infection in hemodialysis patients and determination of HCV genotype distribution].
Bozdayi G; Rota S; Verdi H; Derici U; Sindel S; Bali M; Başay T
Mikrobiyol Bul; 2002; 36(3-4):291-300. PubMed ID: 12838663
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis C in a community in Upper Egypt: I. Cross-sectional survey.
Nafeh MA; Medhat A; Shehata M; Mikhail NN; Swifee Y; Abdel-Hamid M; Watts S; Fix AD; Strickland GT; Anwar W; Sallam I
Am J Trop Med Hyg; 2000; 63(5-6):236-41. PubMed ID: 11421370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
